|
rs10088218
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASCAT |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
23535730 |
2013 |
|
rs10088218
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASDB |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
23535730 |
2013 |
|
rs10088218
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
BEFREE |
Two loci were associated with ovarian cancer risk in BRCA1 carriers; rs10088218 per-allele HR = 0.89 (95% CI: 0.81-0.99) P-trend = 0.029, rs2665390 HR = 1.25 (95% CI: 1.10-1.42) P-trend = 6.1 × 10(-4).
|
22253144 |
2012 |
|
rs10088218
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
|
20852632 |
2010 |
|
rs10088218
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASCAT |
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
|
20852632 |
2010 |
|
rs1243180
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
BEFREE |
We genotyped two tightly linked single-nucleotide polymorphisms (SNPs) at MLLT10 associated with meningioma (rs12770228) or ovarian cancer (rs1243180), and tested for associations among 295 meningioma cases, 606 glioma cases and 646 noncancer controls, all of European descent.
|
24755950 |
2015 |
|
rs1243180
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASDB |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
23535730 |
2013 |
|
rs1243180
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASCAT |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
23535730 |
2013 |
|
rs17631303
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASCAT |
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
23544013 |
2013 |
|
rs17631303
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
BEFREE |
In addition, we identified two novel ovarian cancer risk modifier loci: 17q21.31 (rs17631303, P = 1.4 × 10(-8), HR = 1.27, 95% CI: 1.17-1.38) and 4q32.3 (rs4691139, P = 3.4 × 10(-8), HR = 1.20, 95% CI: 1.17-1.38).
|
23544013 |
2013 |
|
rs17631303
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASDB |
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
23544013 |
2013 |
|
rs2665390
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
BEFREE |
Two loci were associated with ovarian cancer risk in BRCA1 carriers; rs10088218 per-allele HR = 0.89 (95% CI: 0.81-0.99) P-trend = 0.029, rs2665390 HR = 1.25 (95% CI: 1.10-1.42) P-trend = 6.1 × 10(-4).
|
22253144 |
2012 |
|
rs2665390
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
|
20852632 |
2010 |
|
rs2665390
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASCAT |
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.
|
20852632 |
2010 |
|
rs3814113
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASCAT |
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
23544013 |
2013 |
|
rs3814113
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASDB |
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
23544013 |
2013 |
|
rs3814113
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASDB |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
23535730 |
2013 |
|
rs3814113
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASCAT |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
23535730 |
2013 |
|
rs3814113
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
BEFREE |
BRCA1 mutation carriers with the TT genotype at SNP rs3814113 were predicted to have an ovarian cancer risk to age 80 years of 48%, and those with the CC genotype were predicted to have a risk of 33%.
|
21169536 |
2011 |
|
rs3814113
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASCAT |
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
|
19648919 |
2009 |
|
rs3814113
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.
|
19648919 |
2009 |
|
rs4691139
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASCAT |
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
|
28346442 |
2017 |
|
rs4691139
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASDB |
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
23544013 |
2013 |
|
rs4691139
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
BEFREE |
In addition, we identified two novel ovarian cancer risk modifier loci: 17q21.31 (rs17631303, P = 1.4 × 10(-8), HR = 1.27, 95% CI: 1.17-1.38) and 4q32.3 (rs4691139, P = 3.4 × 10(-8), HR = 1.20, 95% CI: 1.17-1.38).
|
23544013 |
2013 |
|
rs4691139
|
|
Ovarian Carcinoma
|
0.810 |
GeneticVariation
|
GWASCAT |
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
23544013 |
2013 |